82 related articles for article (PubMed ID: 11686320)
1. Human thrombi contain an abundance of active thrombin.
Mutch NJ; Robbie LA; Booth NA
Thromb Haemost; 2001 Oct; 86(4):1028-34. PubMed ID: 11686320
[TBL] [Abstract][Full Text] [Related]
2. The association between seated immobility and local lower-limb venous coagulability in healthy adult volunteers: a simulation of prolonged travel immobility.
Ansari MT; Mahmood MT; Karlberg JP
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):335-41. PubMed ID: 16788308
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin-related antigens in human aortic intima.
Smith EB; Crosbie L; Carey S
Semin Thromb Hemost; 1996; 22(4):347-50. PubMed ID: 8944420
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
[TBL] [Abstract][Full Text] [Related]
5. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
de Bosch NB; Mosesson MW; Ruiz-Sáez A; Echenagucia M; Rodriguez-Lemoin A
Thromb Haemost; 2002 Aug; 88(2):253-8. PubMed ID: 12195697
[TBL] [Abstract][Full Text] [Related]
7. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.
Diebold I; Djordjevic T; Hess J; Görlach A
Thromb Haemost; 2008 Dec; 100(6):1021-8. PubMed ID: 19132225
[TBL] [Abstract][Full Text] [Related]
8. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
Nakamura R; Umemura K; Hashimmoto H; Urano T
Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen contains cryptic PAI-1 binding sites that are exposed on binding to solid surfaces or limited proteolysis.
Smolarczyk K; Boncela J; Szymanski J; Gils A; Cierniewski CS
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2679-84. PubMed ID: 16210568
[TBL] [Abstract][Full Text] [Related]
10. Specific determination of plasmatic thrombin activity.
Stief TW
Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
[TBL] [Abstract][Full Text] [Related]
11. [Use of synthetic chromogenic substrates for the control of antithrombosis therapy with small doses of heparin].
Bokarew IM; Butorow WN; Gordejew PS; Kusnezow WA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):142-9. PubMed ID: 6177595
[No Abstract] [Full Text] [Related]
12. [Inducing conformational changes in thrombin by ligands as a way of regulating its activity].
Gershkovich AA
Biokhimiia; 1996 Jul; 61(7):1139-51. PubMed ID: 9035728
[TBL] [Abstract][Full Text] [Related]
13. Understanding thrombin and hemostasis.
Fenton JW; Ofosu FA; Brezniak DV; Hassouna HI
Hematol Oncol Clin North Am; 1993 Dec; 7(6):1107-19. PubMed ID: 8294310
[TBL] [Abstract][Full Text] [Related]
14. Soluble fibrin species in arterial thrombi.
Sandbaek G; Bjørnsen S; Sobel JH; Nieuwenhuizen W; Matsueda G; Brosstad F
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):1-5. PubMed ID: 10691094
[TBL] [Abstract][Full Text] [Related]
15. Thrombus-induced endothelial dysfunction: Hemoglobin and fibrin decrease nitric oxide bioactivity without altering eNOS.
Davis MR; Fitzpatrick CM; Dixon PM; Kashyap VS
J Surg Res; 2004 Nov; 122(1):121-9. PubMed ID: 15522324
[TBL] [Abstract][Full Text] [Related]
16. Vibrio extracellular protease with prothrombin activation and fibrinolytic activities.
Kwon JY; Chang AK; Park JE; Shin SY; Yoon SM; Lee JS
Int J Mol Med; 2007 Jan; 19(1):157-63. PubMed ID: 17143560
[TBL] [Abstract][Full Text] [Related]
17. Dyslipidemias and fibrinolysis.
Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
[TBL] [Abstract][Full Text] [Related]
18. A model of in vivo human venous thrombosis that confirms changes in the release of specific soluble cell adhesion molecules in experimental venous thrombogenesis.
Quarmby J; Smith A; Collins M; Cederholm-Williams S; Burnand K
J Vasc Surg; 1999 Jul; 30(1):139-47. PubMed ID: 10394164
[TBL] [Abstract][Full Text] [Related]
19. A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury.
Shim K; Zhu H; Westfield LA; Sadler JE
Blood; 2004 Jul; 104(2):415-9. PubMed ID: 15039280
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
